scholarly article | Q13442814 |
P50 | author | Tomasz Misztal | Q56285614 |
Dariusz Pawlak | Q28671981 | ||
Tomasz Rusak | Q57054571 | ||
Malgorzata Karbowska | Q64683473 | ||
Natalia Marcinczyk | Q89447116 | ||
P2093 | author name string | Tomasz W Kaminski | |
Lukasz Smyk | |||
P2860 | cites work | Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. | Q39125093 |
Aspects of platelet disturbances in haemodialysis patients | Q41995193 | ||
A highly reproducible model of arterial thrombosis in rats | Q42520659 | ||
Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. | Q43467792 | ||
Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway | Q44141875 | ||
The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis | Q45398007 | ||
Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice | Q46408274 | ||
Anthranilic acid-uraemic toxin damaged red cell's membrane | Q46819588 | ||
Elevation of circulating endothelial microparticles in patients with chronic renal failure. | Q46888760 | ||
New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant | Q46927358 | ||
Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure. | Q48727418 | ||
Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways. | Q48940858 | ||
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). | Q53150011 | ||
Human erythrocyte anion permeabilities measured under conditions of net charge transfer | Q24537670 | ||
TEG and ROTEM: technology and clinical applications | Q26830530 | ||
Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective | Q26858825 | ||
Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo | Q28192997 | ||
Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate | Q31142636 | ||
Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells | Q35364712 | ||
Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor | Q35532690 | ||
Thrombosis in the uremic milieu--emerging role of "thrombolome". | Q35532702 | ||
Indoxyl sulphate and kidney disease: Causes, consequences and interventions | Q35736317 | ||
Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages | Q35939396 | ||
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis | Q36068812 | ||
Thrombelastography/thromboelastometry. | Q36077355 | ||
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease | Q36260141 | ||
Indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release | Q36329565 | ||
The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia | Q36417926 | ||
Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts | Q36746081 | ||
In vivo thrombus formation | Q36884296 | ||
Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access | Q37641160 | ||
Disorders of hemostasis associated with chronic kidney disease | Q37730768 | ||
Indoxyl Sulfate Is a Nephro-Vascular Toxin | Q37783421 | ||
Red blood cell microparticles: clinical relevance | Q38117133 | ||
Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment | Q67694345 | ||
Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels | Q69654019 | ||
A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin | Q71115021 | ||
The electronic aggregometer: a novel device for assessing platelet behavior in blood | Q71246388 | ||
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse | Q74817597 | ||
Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa | Q84002651 | ||
HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma | Q84424763 | ||
In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin | Q86113659 | ||
Antithrombotic effects of pyridinium compounds formed from trigonelline upon coffee roasting | Q87480452 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P577 | publication date | 2017-07-19 | |
P1433 | published in | Toxins | Q15724569 |
P1476 | title | The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models | |
P478 | volume | 9 |
Q91657005 | A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients |
Q92071323 | Assessment of Thrombotic and Bleeding Tendency in Two Mouse Models of Chronic Kidney Disease: Adenine-Diet and 5/6th Nephrectomy |
Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
Q59805481 | Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3 |
Q52726373 | Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated. |
Q58694064 | Introduction to the Special Issue on "Novel Issues in Uremic Toxicity" |
Q96302971 | Neurobehavioral effects of uremic toxin-indoxyl sulfate in the rat model |
Q64270924 | The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease |
Q57473313 | Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease |
Search more.